Bayard D. Clarkson

11.8k total citations · 2 hit papers
156 papers, 9.4k citations indexed

About

Bayard D. Clarkson is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Bayard D. Clarkson has authored 156 papers receiving a total of 9.4k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Hematology, 52 papers in Genetics and 45 papers in Oncology. Recurrent topics in Bayard D. Clarkson's work include Chronic Lymphocytic Leukemia Research (44 papers), Chronic Myeloid Leukemia Treatments (32 papers) and Acute Myeloid Leukemia Research (31 papers). Bayard D. Clarkson is often cited by papers focused on Chronic Lymphocytic Leukemia Research (44 papers), Chronic Myeloid Leukemia Treatments (32 papers) and Acute Myeloid Leukemia Research (31 papers). Bayard D. Clarkson collaborates with scholars based in United States, Germany and United Kingdom. Bayard D. Clarkson's co-authors include Renato Baserga, A Strife, Toby Gee, Jerrold Fried, Darren R. Veach, David Wisniewski, William G. Bornmann, Benjamín Koziner, J. E. Till and Paul A. Marks and has published in prestigious journals such as Nature, New England Journal of Medicine and Cell.

In The Last Decade

Bayard D. Clarkson

156 papers receiving 8.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Control of proliferation in animal cells

1974 960 citations Bayard D. Clarkson, Renato Baserga profile →
Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571).

2002 731 citations William G. Bornmann, Darren R. Veach et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bayard D. Clarkson United States	51	3.3k	3.1k	2.3k	1.8k	1.4k	156	9.4k
Sanford A. Stass United States	44	3.7k 1.1×	2.3k 0.7×	1.8k 0.8×	828 0.4×	1.4k 1.0×	143	7.5k
J. Ford Switzerland	26	1.8k 0.6×	4.9k 1.6×	2.3k 1.0×	3.4k 1.8×	872 0.6×	58	8.6k
Jacqueline Whang‐Peng Taiwan	63	5.6k 1.7×	1.7k 0.5×	5.0k 2.2×	1.8k 1.0×	878 0.6×	319	15.0k
Elisabeth Paietta United States	61	4.7k 1.4×	7.8k 2.5×	3.0k 1.3×	2.6k 1.4×	4.3k 3.0×	278	12.9k
Selina M. Luger United States	47	2.9k 0.9×	5.4k 1.7×	2.9k 1.3×	1.1k 0.6×	3.2k 2.3×	304	9.7k
Jerry A. Katzmann United States	54	5.1k 1.6×	5.4k 1.7×	2.6k 1.1×	2.6k 1.4×	244 0.2×	171	10.6k
Susan M. Blaney United States	63	5.0k 1.5×	1.2k 0.4×	3.3k 1.4×	2.5k 1.4×	1.3k 0.9×	267	11.4k
Gert J. Ossenkoppele Netherlands	53	4.4k 1.3×	8.6k 2.8×	2.8k 1.2×	2.8k 1.5×	2.3k 1.6×	279	12.3k
Sydney E. Salmon United States	47	7.0k 2.1×	4.7k 1.5×	5.2k 2.3×	927 0.5×	405 0.3×	136	13.4k
Michael R. Loken United States	52	2.8k 0.9×	4.5k 1.5×	1.6k 0.7×	1.3k 0.7×	1.3k 0.9×	218	9.6k

Countries citing papers authored by Bayard D. Clarkson

Since Specialization

Citations

This map shows the geographic impact of Bayard D. Clarkson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bayard D. Clarkson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bayard D. Clarkson more than expected).

Fields of papers citing papers by Bayard D. Clarkson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bayard D. Clarkson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bayard D. Clarkson. The network helps show where Bayard D. Clarkson may publish in the future.

Co-authorship network of co-authors of Bayard D. Clarkson

This figure shows the co-authorship network connecting the top 25 collaborators of Bayard D. Clarkson. A scholar is included among the top collaborators of Bayard D. Clarkson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bayard D. Clarkson. Bayard D. Clarkson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Darie, Costel C., et al.. (2016). Exosome mediated growth effect on the non-growing pre-B acute lymphoblastic leukemia cells at low starting cell density.. PubMed. 8(9). 3614–3629. 14 indexed citations

Guo, Tianhua, Narasimhan P. Agaram, Darren R. Veach, et al.. (2009). Mechanisms of Sunitinib Resistance in Gastrointestinal Stromal Tumors Harboring KIT AY502-3ins Mutation: An In vitro Mutagenesis Screen for Drug Resistance. Clinical Cancer Research. 15(22). 6862–6870. 69 indexed citations

Liang, Xiquan, Darren R. Veach, David Wisniewski, et al.. (2006). Quantification of change in phosphorylation of BCR‐ABL kinase and its substrates in response to Imatinib treatment in human chronic myelogenous leukemia cells. PROTEOMICS. 6(16). 4554–4564. 40 indexed citations

Wolff, Nicholas C., Darren R. Veach, William P. Tong, et al.. (2005). PD166326, a novel tyrosine kinase inhibitor, has greater antileukemic activity than imatinib mesylate in a murine model of chronic myeloid leukemia. Blood. 105(10). 3995–4003. 51 indexed citations

Tafuri, Agostino, et al.. (1994). Combination of hematopoietic growth factors containing IL-3 induce acute myeloid leukemia cell sensitization to cycle specific and cycle non-specific drugs.. IRIS Research product catalog (Sapienza University of Rome). 8(5). 749–57. 23 indexed citations

Gaynor, Jeffrey J., Eric J. Feuer, Danny Wu, et al.. (1993). On the Use of Cause-Specific Failure and Conditional Failure Probabilities: Examples from Clinical Oncology Data. Journal of the American Statistical Association. 88(422). 400–409. 396 indexed citations

Straus, David J., George Y. Wong, John Liu, et al.. (1991). Small non-cleaved-cell lymphoma (undifferentiated lymphoma, Burkitt's type) in American adults: results with treatment designed for acute lymphoblastic leukemia. The American Journal of Medicine. 90(3). 328–337. 41 indexed citations

Gulati, Subhash C., et al.. (1991). Factors affecting the outcome of autologous bone marrow transplantation. Annals of Oncology. 2. 51–55. 6 indexed citations

Gulati, Subhash C., Jens Atzpodien, Timothy J. Triche, et al.. (1989). In Vitro Chemosensitivity of Two Ewing's Sarcoma Cell Lines: Implication for Autologous Bone Marrow Transplantation. Cancer Investigation. 7(5). 411–416. 9 indexed citations

10.

Yahalom, Joachim, Subhash C. Gulati, Brenda Shank, Bayard D. Clarkson, & Zvi Fuks. (1989). Total lymphoid irradiation, high-dose chemotherapy and autologous bone marrow transplantation for chemotherapy-resistant Hodgkin's disease. International Journal of Radiation Oncology*Biology*Physics. 17(5). 915–922. 31 indexed citations

11.

Shimazaki, Chihiro, Subhash C. Gulati, Jens Atzpodien, et al.. (1988). Ex vivo Treatment of Myeloma Cells by 4-Hydroperoxycyclophosphamide and VP-16–213. Acta Haematologica. 80(1). 17–22. 7 indexed citations

12.

Lieberman, Philip, Daniel A. Filippa, David J. Straus, et al.. (1986). Evaluation of malignant lymphomas using three classifications and the working formulation. The American Journal of Medicine. 81(3). 365–380. 26 indexed citations

13.

Clarkson, Bayard D., Stephen B. Ellis, Claudia Little, et al.. (1985). Acute lymphoblastic leukemia in adults.. PubMed. 12(2). 160–79. 150 indexed citations

14.

Fried, Jerrold, et al.. (1982). Effects of hoechst 33342 on survival and growth of two tumor cell lines and on hematopoietically normal bone marrow cells. Cytometry. 3(1). 42–47. 50 indexed citations

15.

Mertelsmann, Roland, Toby Gee, Sanford Kempin, et al.. (1981). Treatment of acute nonlymphocytic leukemia in adults: Response to 2,2-anhydro-1-B-D-Arabinofuranosyl-5-fluorocytosine and thioguanine on the L-12 protocol. Cancer. 48(10). 2136–2142. 10 indexed citations

16.

Clarkson, Bayard D., Paul A. Marks, & J. E. Till. (1978). Differentiation of normal and neoplastic hematopoietic cells. 325 indexed citations

17.

Koziner, Benjamín, Daniel A. Filippa, Roland Mertelsmann, et al.. (1977). Characterization of malignant lymphomas in leukemic phase by multiple differentiation markers of mononuclear cells. The American Journal of Medicine. 63(4). 556–567. 90 indexed citations

18.

Fried, Jerrold, Xenophon Yataganas, Takeshi Kitahara, et al.. (1976). Quantitative analysis of flow microfluorometric data from asynchronous and drug-treated cell populations. Computers and Biomedical Research. 9(3). 277–290. 25 indexed citations

19.

Polliack, Aaron, Frederick P. Siegal, Bayard D. Clarkson, et al.. (1975). A Scanning Electron Microscopy and Immunological Study of 84 Cases of Lymphacytic Leukaemia and Related Lymphoproliferative Disorders. Scandinavian Journal of Haematology. 15(5). 359–376. 21 indexed citations

20.

Clarkson, Bayard D. & Renato Baserga. (1974). Control of proliferation in animal cells. 960 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact